Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27.


Journal

Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 1 3 2020
medline: 2 2 2021
entrez: 1 3 2020
Statut: ppublish

Résumé

The goal of this study was to characterize a Swedish family with members affected by spinocerebellar ataxia 27 (SCA27), a rare autosomal dominant disease caused by mutations in fibroblast growth factor 14 (FGF14). Despite normal structural neuroimaging, psychiatric manifestations and intellectual disability are part of the SCA27 phenotype raising the need for functional neuroimaging. Here, we used clinical assessments, structural and functional neuroimaging to characterize these new SCA27 patients. Since one patient presents with a psychotic disorder, an exploratory study of markers of schizophrenia associated with GABAergic neurotransmission was performed in fgf14 A comprehensive characterization that included clinical assessments, cognitive tests, structural neuroimaging studies, brain metabolism with Nine patients had ataxia, and all affected patients harboured an interstitial deletion of chromosome 13q33.1 encompassing the entire FGF14 and integrin subunit beta like 1 (ITGBL1) genes. New features for SCA27 were identified: congenital onset, psychosis, attention deficit hyperactivity disorder and widespread hypometabolism that affected the medial prefrontal cortex (mPFC) in all patients. Hypometabolism in the PFC was far more pronounced in a SCA27 patient with psychosis. Reduced expression of VGAT was found in the mPFC of fgf14 This is the second largest SCA27 family identified to date. We provide new clinical and preclinical evidence for a significant psychiatric component in SCA27, strengthening the hypothesis of FGF14 as an important modulator of psychiatric disease.

Identifiants

pubmed: 32112487
doi: 10.1111/joim.13052
pmc: PMC10123866
mid: NIHMS1883460
doi:

Substances chimiques

ITGBL1 protein, human 0
Integrin beta1 0
Radiopharmaceuticals 0
Vesicular Inhibitory Amino Acid Transport Proteins 0
Viaat protein, mouse 0
fibroblast growth factor 14 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-115

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA047102
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH095995
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111107
Pays : United States

Informations de copyright

© 2020 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.

Références

Neurogenetics. 2009 Oct;10(4):371-4
pubmed: 19471976
Eur J Paediatr Neurol. 2014 May;18(3):413-5
pubmed: 24252256
Neuropharmacology. 2016 Dec;111:107-118
pubmed: 27580848
Eur J Med Genet. 2019 Mar;62(3):172-176
pubmed: 30017992
Behav Brain Res. 2019 Jan 1;356:257-265
pubmed: 30189289
Eur J Hum Genet. 2005 Jan;13(1):118-20
pubmed: 15470364
Tremor Other Hyperkinet Mov (N Y). 2018 Jan 30;8:534
pubmed: 29416937
Arch Neurol. 1984 Aug;41(8):825-9
pubmed: 6331818
FASEB J. 2016 Jun;30(6):2171-86
pubmed: 26917740
Mol Psychiatry. 2002;7(5):484-92
pubmed: 12082566
Neurology. 2004 Sep 14;63(5):936
pubmed: 15365159
J Biol Chem. 2013 Jul 5;288(27):19370-85
pubmed: 23640885
Front Cell Neurosci. 2017 Apr 19;11:103
pubmed: 28469558
Neurosci Lett. 2012 Jun 27;520(1):16-9
pubmed: 22579694
Cerebellum. 2019 Jun;18(3):649-653
pubmed: 30607796
Mol Neurobiol. 2016 Dec;53(10):7254-7270
pubmed: 26687232
Neurobiol Dis. 2009 Jan;33(1):81-8
pubmed: 18930825
Psychiatry Res. 2019 Jan;271:535-540
pubmed: 30553101
Neuron. 2002 Jul 3;35(1):25-38
pubmed: 12123606
Front Neural Circuits. 2018 May 16;12:37
pubmed: 29867371
Schizophr Res. 2015 Sep;167(1-3):84-90
pubmed: 25458856
Neurobiol Dis. 2007 Apr;26(1):14-26
pubmed: 17236779
Cortex. 2013 Apr;49(4):1063-72
pubmed: 23040316
Eur J Paediatr Neurol. 2015 Mar;19(2):271-3
pubmed: 25530029
Curr Mol Med. 2015;15(2):146-67
pubmed: 25732149
Acta Pharmacol Sin. 2018 May;39(5):733-753
pubmed: 29565038
J Neurosci. 2007 Oct 31;27(44):12033-44
pubmed: 17978045
Harv Rev Psychiatry. 2010 May-Jun;18(3):173-89
pubmed: 20415633
Transl Psychiatry. 2016 May 10;6:e806
pubmed: 27163207
Sci Rep. 2017 Oct 23;7(1):13855
pubmed: 29062094
Proteomes. 2019 Jan 23;7(1):
pubmed: 30678040
Neuropediatrics. 2017 Apr;48(2):131
pubmed: 28192817
J Neurosci. 2015 Apr 29;35(17):6752-69
pubmed: 25926453
Mov Disord. 2006 Mar;21(3):396-401
pubmed: 16211615
Arch Gen Psychiatry. 1988 Jun;45(6):523-32
pubmed: 2897836
Transl Psychiatry. 2019 Oct 21;9(1):264
pubmed: 31636253
Am J Hum Genet. 2003 Jan;72(1):191-9
pubmed: 12489043
J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):301-309
pubmed: 27965395
ACS Chem Neurosci. 2018 May 16;9(5):976-987
pubmed: 29359916
Neurogenetics. 2015 Jul;16(3):233-6
pubmed: 25566820
Brain Dev. 2012 Mar;34(3):230-3
pubmed: 21600715
PLoS One. 2017 Dec 18;12(12):e0190030
pubmed: 29253853
Schizophr Bull. 2015 Jan;41(1):180-91
pubmed: 24361861
Cerebellum. 2018 Aug;17(4):465-476
pubmed: 29527639

Auteurs

M Paucar (M)

From the, Departments of, Department of, Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of, Neurology, Karolinska University Hospital, Stockholm, Sweden.

J Lundin (J)

Department of, Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

T Alshammari (T)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.
Department of, Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Å Bergendal (Å)

From the, Departments of, Department of, Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

M Lindefeldt (M)

Department of, Pediatric Neurology, Astrid Lindgren's Hospital, Stockholm, Sweden.

M Alshammari (M)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.
Department of, Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

G Solders (G)

From the, Departments of, Department of, Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of, Neurophysiology, Karolinska University Hospital, Stockholm, Sweden.

J Di Re (J)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.
Neuroscience Graduate Program, The University of Texas Medical Branch, Galveston, TX, USA.

I Savitcheva (I)

Departments of, Department of, Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.

T Granberg (T)

From the, Departments of, Department of, Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of, Radiology, Karolinska University Hospital, Stockholm, Sweden.

F Laezza (F)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.

E Iwarsson (E)

Department of, Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

P Svenningsson (P)

From the, Departments of, Department of, Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of, Neurology, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH